UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 103 filers reported holding UROGEN PHARMA LTD in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $266,793 | -49.7% | 19,043 | -62.8% | 0.00% | – |
| Q2 2023 | $530,097 | -5.0% | 51,217 | -15.2% | 0.00% | – |
| Q1 2023 | $558,000 | +9299900.0% | 60,391 | +8576.9% | 0.00% | – |
| Q4 2022 | $6 | -100.0% | 696 | -98.7% | 0.00% | – |
| Q3 2022 | $438,000 | +277.6% | 52,678 | +274.7% | 0.00% | – |
| Q2 2022 | $116,000 | -83.8% | 14,059 | -82.8% | 0.00% | – |
| Q1 2022 | $714,000 | +20.0% | 81,867 | +30.8% | 0.00% | – |
| Q4 2021 | $595,000 | -45.6% | 62,587 | -3.7% | 0.00% | – |
| Q3 2021 | $1,094,000 | -16.4% | 65,013 | -24.2% | 0.00% | – |
| Q2 2021 | $1,309,000 | -31.6% | 85,732 | -12.7% | 0.00% | – |
| Q1 2021 | $1,913,000 | +24.9% | 98,157 | +15.5% | 0.00% | – |
| Q4 2020 | $1,532,000 | -22.8% | 84,982 | -17.2% | 0.00% | – |
| Q3 2020 | $1,984,000 | -32.8% | 102,658 | -9.2% | 0.00% | -100.0% |
| Q2 2020 | $2,951,000 | +26.8% | 113,037 | -13.3% | 0.00% | 0.0% |
| Q1 2020 | $2,328,000 | -51.5% | 130,448 | -9.4% | 0.00% | 0.0% |
| Q4 2019 | $4,803,000 | +960.3% | 143,942 | +656.9% | 0.00% | – |
| Q3 2019 | $453,000 | +166.5% | 19,018 | +269.6% | 0.00% | – |
| Q2 2019 | $170,000 | -46.9% | 5,146 | -24.1% | 0.00% | – |
| Q3 2018 | $320,000 | +210.7% | 6,778 | +227.0% | 0.00% | – |
| Q1 2018 | $103,000 | -44.3% | 2,073 | -58.2% | 0.00% | – |
| Q4 2017 | $185,000 | +10.1% | 4,960 | -4.1% | 0.00% | – |
| Q3 2017 | $168,000 | – | 5,171 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
| Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
| Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
| AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
| Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
| EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
| RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
| Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |